Global Swine Epidemic Diarrhea Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Swine Epidemic Diarrhea Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Swine epidemic diarrhea virus (PEDV) is the causative agent of porcine epidemic diarrhea (PED), an acute and highly contagious enteric viral disease.
Swine Epidemic Diarrhea Vaccines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Swine Epidemic Diarrhea Vaccines market is projected to reach US$ 1907 million in 2029, increasing from US$ 1354 million in 2022, with the CAGR of 5.0% during the period of 2024 to 2029. Demand from Piglets and Adults Pigs are the major drivers for the industry.
The Animal Healthcare market is primarily driven by the increasing awareness about animal health and well-being, coupled with the rising prevalence of various animal diseases. Pet ownership has grown, leading to higher demand for veterinary services and products. Additionally, the growth of the livestock industry to meet global food demand further boosts the need for animal healthcare products. Advances in veterinary medicine and technology are also driving market growth, enabling better diagnosis, treatment, and preventive care for animals. However, challenges include regulatory complexities and the high cost of certain treatments, which can hinder accessibility for some pet owners or farmers. Striking a balance between quality care and affordability is crucial for the sustainable growth of the animal healthcare market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Swine Epidemic Diarrhea Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
CAVAC
Green Cross Veterinary Products
Harrisvaccines, Inc.
Komipharm
Nisseiken
Qilu Animal Health
Zoetis
Segment by Type
Live Vaccines
Killed Vaccines
Piglets
Adults Pigs
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Swine Epidemic Diarrhea Vaccines market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Swine Epidemic Diarrhea Vaccines introduction, etc. Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Swine Epidemic Diarrhea Vaccines market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Swine Epidemic Diarrhea Vaccines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Swine Epidemic Diarrhea Vaccines market is projected to reach US$ 1907 million in 2029, increasing from US$ 1354 million in 2022, with the CAGR of 5.0% during the period of 2024 to 2029. Demand from Piglets and Adults Pigs are the major drivers for the industry.
The Animal Healthcare market is primarily driven by the increasing awareness about animal health and well-being, coupled with the rising prevalence of various animal diseases. Pet ownership has grown, leading to higher demand for veterinary services and products. Additionally, the growth of the livestock industry to meet global food demand further boosts the need for animal healthcare products. Advances in veterinary medicine and technology are also driving market growth, enabling better diagnosis, treatment, and preventive care for animals. However, challenges include regulatory complexities and the high cost of certain treatments, which can hinder accessibility for some pet owners or farmers. Striking a balance between quality care and affordability is crucial for the sustainable growth of the animal healthcare market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Swine Epidemic Diarrhea Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
CAVAC
Green Cross Veterinary Products
Harrisvaccines, Inc.
Komipharm
Nisseiken
Qilu Animal Health
Zoetis
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Piglets
Adults Pigs
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Swine Epidemic Diarrhea Vaccines market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Swine Epidemic Diarrhea Vaccines introduction, etc. Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Swine Epidemic Diarrhea Vaccines market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices